Journal
CURRENT OPINION IN STRUCTURAL BIOLOGY
Volume 21, Issue 2, Pages 150-160Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.sbi.2011.01.011
Keywords
-
Categories
Funding
- QB3-Berkeley Distinguished Postdoctoral Fellowship
- Louisiana Board of Regents Post-Katrina Support Fund Initiative [LEQSF(2007-12)-ENH-PKSFI-PRS-01]
- NIH [R01-GM062868]
- NSF [EF-0623664]
- Office Of The Director
- EPSCoR [1003897] Funding Source: National Science Foundation
Ask authors/readers for more resources
Improved rational drug design methods are needed to lower the cost and increase the success rate of drug discovery and development. Alchemical binding free energy calculations, one potential tool for rational design, have progressed rapidly over the past decade, but still fall short of providing robust tools for pharmaceutical engineering. Recent studies, especially on model receptor systems, have clarified many of the challenges that must be overcome for robust predictions of binding affinity to be useful in rational design. In this review, inspired by a recent joint academic/industry meeting organized by the authors, we discuss these challenges and suggest a number of promising approaches for overcoming them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available